GSTP1 and neoplasm: No significant association was found between GSTP1 polymorphism and BC risk, according to tumor stage or potential hormone-related BC risk factors (age at menarche, postmenopausal use of estrogens, use of oral contraceptives, parity, age at FFTP, BMI or WHR) (data not shown).